The emerging landscape of performance-enhancing peptides modulating GH-IGF1 axis: bridging the gap between clinical evidence and patient self-administration - Poll - MDSpire

The emerging landscape of performance-enhancing peptides modulating GH-IGF1 axis: bridging the gap between clinical evidence and patient self-administration

  • By

  • Aleksander Dominikowski

  • Zofia Rękoś

  • Michał Olejarz

  • Ewelina Szczepanek-Parulska

  • Remigiusz Domin

  • Marek RuchaŁa

  • June 18, 2026

  • 0 min

Share

Original Source(s)

The emerging landscape of performance-enhancing peptides modulating GH-IGF1 axis: bridging the gap between clinical evidence and patient self-administration

  • by Aleksander Dominikowski, Zofia Rękoś, Michał Olejarz, Ewelina Szczepanek-Parulska, Remigiusz Domin, Marek RuchaŁa

  • June 18, 2026

Related Content

FDA Expands CAPVAXIVE Pediatric Use

Phase 3 data showed noninferior immune responses vs pneumococcal 23-valent polysaccharide vaccine in pediatric patients at increased risk.

Acute glucose stimulation drives coordinated translational reprogramming in primary pancreatic islets: from global remodeling to fine-tuned insulin synthesis

Central precocious puberty as the initial manifestation of multisystem involvement caused by de novo heterozygous KMT2B mutation and STS hemizygous deletion: a case report